Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 451–465 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2425 Liquid Biopsy Circulating-Free DNA EGFR Mutation Test This test identifies and quantifies specific mutations in the EGFR gene using circulating-free DNA from a blood sample.	Peripheral Whole Blood	3 Working Days	2,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["EGFR driver mutations", "Allele frequency"] Parameters [{"name": "EGFR Mutation Detection", "reference_range": "Detected/Not Detected"}] Preparation [] Indications ["Monitoring treatment response in EGFR-mutated cancers", "Detecting emergent resistance mutations (e.g., T790M)", "Guiding targeted therapy decisions"] Measurement technique Confirm with laboratory Codes LOINC: 92819-2 ICD-10: Z15.0 Clinical summary This test identifies and quantifies specific mutations in the EGFR gene using circulating-free DNA from a blood sample.
TEST-529 Liquid Biopsy Colon Cancer Test This test evaluates circulating tumor DNA (ctDNA) in blood for genetic mutations associated with colorectal cancer.	Peripheral whole blood	21 Working Days	4,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Circulating tumor DNA (ctDNA)", "Actionable mutations (KRAS, NRAS, BRAF)", "Microsatellite Instability (MSI) status"] Parameters [{"name": "KRAS Mutation Status", "reference_range": "Negative/Positive"}, {"name": "NRAS Mutation Status", "reference_range": "Negative/Positive"}, {"name": "BRAF Mutation Status", "reference_range": "Negative/Positive"}, {"name": "MSI Status", "reference_range": "Stable/Unstable"}] Preparation ["No fasting required", "Ensure hydration", "Provide relevant clinical records"] Indications ["Detection of actionable mutations in colorectal cancer", "Monitoring disease progression", "Assessing treatment response", "Detecting minimal residual disease"] Measurement technique Confirm with laboratory Codes LOINC: 94135-0 ICD-10: C18.9, C19, C20 Clinical summary This test evaluates circulating tumor DNA (ctDNA) in blood for genetic mutations associated with colorectal cancer.
TEST-511 Liquid Biopsy Lung Cancer Test (NGS Panel) This test identifies actionable genetic mutations in cell-free DNA (ctDNA) from a blood sample to guide lung cancer treatment.	Peripheral blood (plasma ctDNA)	21 working days	4,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Actionable mutations in ctDNA", "EGFR", "ALK", "ROS1", "BRAF", "KRAS", "MET"] Parameters [] Preparation ["No specific fasting required", "Inform laboratory of recent blood transfusion or surgery"] Indications ["Guiding targeted therapy for lung cancer", "Monitoring treatment response", "Detecting resistance mutations"] Measurement technique Confirm with laboratory Codes LOINC: 94498-5 ICD-10: C34.9 Clinical summary This test identifies actionable genetic mutations in cell-free DNA (ctDNA) from a blood sample to guide lung cancer treatment.
TEST-6109 LPA Gene (LPA Deficiency, Congenital) Genetic Test This test identifies genetic variants in the LPA gene responsible for congenital lipoprotein(a) deficiency.	Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	21 – 28 Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Genetic variants in the LPA gene", "Single nucleotide variants", "Insertions/Deletions", "Copy number variations"] Parameters [] Preparation ["No fasting or special preparation required", "Mandatory pre-test genetic counseling session", "Bring prior lipid profiles and physician referral forms"] Indications ["Diagnosis of congenital lipoprotein(a) deficiency", "Carrier screening", "Family risk stratification", "Neonates with suspected inborn errors of lipoprotein metabolism"] Measurement technique Confirm with laboratory Codes LOINC: 94514-9 ICD-10: E78.9, Z13.22 Clinical summary This test identifies genetic variants in the LPA gene responsible for congenital lipoprotein(a) deficiency.
TEST-5418 LRMDA Gene (Oculocutaneous Albinism Type 7) Genetic Test This genetic test evaluates the LRMDA gene for pathogenic variants associated with Oculocutaneous Albinism Type 7 (OCA7).	Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	18-21 Working Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["LRMDA gene sequence", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation [] Indications ["Clinical suspicion of Oculocutaneous Albinism Type 7 (OCA7)", "Family history of albinism", "Need for genetic counselling and family planning"] Measurement technique Confirm with laboratory Codes LOINC: 90396-3 ICD-10: E70.310 Clinical summary This genetic test evaluates the LRMDA gene for pathogenic variants associated with Oculocutaneous Albinism Type 7 (OCA7).
TEST-1411 Lung Cancer Mutation Panel 5 (EGFR, KRAS, BRAF, ALK1, ROS1) Test This diagnostic test evaluates for the presence of specific genetic mutations (EGFR, KRAS, BRAF, ALK1, ROS1) in formalin-fixed paraffin-embedded (FFPE) tumor tissue.	Formalin-Fixed Paraffin-Embedded (FFPE) Tumor Tissue Block or Archival Slides	5–7 working days	4,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["EGFR gene mutations", "KRAS gene mutations", "BRAF gene mutations", "ALK1 gene rearrangements", "ROS1 gene rearrangements"] Parameters [] Preparation ["No fasting or special preparation is required from the patient."] Indications ["Diagnosis of non-small cell lung cancer (NSCLC)", "Guidance for targeted therapy selection in NSCLC", "Prediction of treatment response in NSCLC"] Measurement technique Confirm with laboratory Codes LOINC: 93024-1 ICD-10: C34.9, Z85.1 Clinical summary This diagnostic test evaluates for the presence of specific genetic mutations (EGFR, KRAS, BRAF, ALK1, ROS1) in formalin-fixed paraffin-embedded (FFPE) tumor tissue.
TEST-2434 Lung Cancer Mutation Panel Test This test detects actionable genetic mutations in lung tumour tissue to guide targeted cancer therapy.	Archival Tissue Specimen – Formalin-fixed paraffin-embedded (FFPE) tumour block or slides	7 calendar days from sample receipt at laboratory	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["EGFR mutations", "ALK mutations", "ROS1 mutations", "Other key gene mutations"] Parameters [] Preparation ["No special preparation is needed as the test uses previously collected tumour tissue.", "Ensure your physician submits a completed Form 20 and provides the FFPE block or slides."] Indications ["Diagnosis of lung cancer", "Guiding targeted therapy selection", "Tailoring treatment plans based on genomic profile"] Measurement technique Confirm with laboratory Codes LOINC: 51968-1 ICD-10: C34.90 Clinical summary This test detects actionable genetic mutations in lung tumour tissue to guide targeted cancer therapy.
TEST-1420 Lung Cancer Panel 1 (EGFR & ALK1) Test This diagnostic test evaluates tumor tissue for specific genetic mutations (EGFR) and rearrangements (ALK) associated with non-small cell lung cancer.	Tumor Tissue (FFPE Block or Fresh Biopsy)	5–7 Business Days	2,400.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Activating EGFR mutations", "ALK gene rearrangements"] Parameters [] Preparation ["No special preparation required for the patient.", "Sample is an archival tissue specimen (FFPE block or fresh biopsy) obtained during a hospital procedure."] Indications ["Diagnosis of non-small cell lung cancer", "Selection of targeted therapy"] Measurement technique Confirm with laboratory Codes LOINC: 21604-6 ICD-10: C34.9 Clinical summary This diagnostic test evaluates tumor tissue for specific genetic mutations (EGFR) and rearrangements (ALK) associated with non-small cell lung cancer.
TEST-1424 Lung Cancer Panel 2 (EGFR, ALK1, ROS1) Mutation Analysis Test This test identifies specific genetic mutations (EGFR, ALK1, ROS1) in non-small cell lung cancer (NSCLC) tissue samples.	Formalin-Fixed Paraffin-Embedded (FFPE) Tumour Tissue Block / Archival Biopsy Slides	5–7 working days	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["EGFR mutations (Exon 19 deletions, L858R point mutations)", "ALK gene rearrangements", "ROS1 fusions"] Parameters [] Preparation [] Indications ["Histologically confirmed NSCLC diagnosis", "Prior to initiating first-line tyrosine kinase inhibitor therapy", "Upon disease progression to assess resistance mechanisms"] Measurement technique Confirm with laboratory Codes LOINC: 92815-7 ICD-10: C34.90 Clinical summary This test identifies specific genetic mutations (EGFR, ALK1, ROS1) in non-small cell lung cancer (NSCLC) tissue samples.
TEST-1421 Lung Cancer Panel 4: EGFR, ALK, ROS1, MET & PD‑L1 Test This diagnostic test evaluates five key biomarkers (EGFR, ALK, ROS1, MET, PD-L1) in tumor tissue to guide targeted therapy and immunotherapy selection for non-small cell lung cance...	Tumor Tissue (FFPE Block or Biopsy Slides)	5–7 business days	4,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["EGFR mutations", "ALK rearrangements", "ROS1 rearrangements", "MET alterations (fusions/amplifications)", "PD-L1 expression"] Parameters [{"name": "EGFR", "reference_range": "Qualitative (Mutations detected/not detected)"}, {"name": "ALK", "reference_range": "Qualitative (Rearrangement detected/not detected)"}, {"name": "ROS1", "reference_range": "Qualitative (Rearrangement detected/not detected)"}, {"name": "MET", "reference_range": "Qualitative (Fusions/Amplifications detected/not detected)"}, {"name": "PD-L1", "reference_range": "Qualitative (Expression level %)"}] Preparation ["No special patient preparation is needed beyond clinician’s pre-biopsy instructions."] Indications ["Diagnosis of non-small cell lung cancer", "Treatment planning for metastatic or advanced non-small cell lung cancer", "Identifying eligibility for targeted therapies or immunotherapies"] Measurement technique Confirm with laboratory Codes LOINC: 60513-6 ICD-10: C34.9 Clinical summary This diagnostic test evaluates five key biomarkers (EGFR, ALK, ROS1, MET, PD-L1) in tumor tissue to guide targeted therapy and immunotherapy selection for non-small cell lung cancer.
TEST-1407 Lung Cancer Panel 7 (EGFR, BRAF, ALK1, ROS1, MET) Test This test evaluates key genetic mutations and rearrangements in EGFR, BRAF, ALK1, ROS1, and MET genes within a non-small cell lung cancer tumor sample.	Tumor tissue biopsy (formalin‑fixed paraffin‑embedded block or unstained slides)	5–7 business days	4,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["EGFR mutations (exon 19 deletions, L858R, T790M)", "BRAF V600E mutation", "ALK rearrangements", "ROS1 fusions", "MET amplification or exon 14 skipping mutations"] Parameters [] Preparation [] Indications ["Patients with confirmed or strongly suspected Non-Small Cell Lung Cancer (NSCLC)", "Guidance for targeted therapy selection"] Measurement technique Confirm with laboratory Codes LOINC: 92874-8 ICD-10: C34.90 Clinical summary This test evaluates key genetic mutations and rearrangements in EGFR, BRAF, ALK1, ROS1, and MET genes within a non-small cell lung cancer tumor sample.
TEST-747 Malaria (Plasmodium falciparum) Quantitative Test This test detects and quantifies the DNA of Plasmodium falciparum, the parasite causing the most severe form of malaria, in a whole blood sample.	Whole blood (EDTA)	24 hours (phone report) / 36 hours (email report)	1,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Plasmodium falciparum DNA", "Parasite load (DNA copies/mL)"] Parameters [{"name": "Plasmodium falciparum DNA", "reference_range": "Negative (Not Detected)"}] Preparation ["No specific fasting required", "Inform phlebotomist of all current medications, especially antimalarials"] Indications ["Evaluation of febrile travelers", "Monitoring treatment response", "Diagnosis of malaria when RDTs are negative but suspicion remains high", "Assessment of infection severity"] Measurement technique Confirm with laboratory Codes LOINC: 57237-4 ICD-10: B50.9 Clinical summary This test detects and quantifies the DNA of Plasmodium falciparum, the parasite causing the most severe form of malaria, in a whole blood sample.
TEST-734 Marburg, Lassa & Ebola Multiplex Detection and Differentiation (RNA Detection) Qualitative Test This test detects the presence of RNA from Marburg, Lassa, and Ebola viruses in clinical samples.	Whole blood, Serum, Plasma, Cerebrospinal Fluid (CSF), Oral fluid, Swabs	48 hours (email) / 36 hours (urgent phone)	1,400.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Marburg virus RNA", "Lassa virus RNA", "Ebola virus RNA"] Parameters [] Preparation [] Indications ["Suspected viral hemorrhagic fever", "Travel history to endemic regions", "Exposure to individuals with confirmed infection"] Measurement technique Confirm with laboratory Codes LOINC: 94085-4 ICD-10: A98.8 Clinical summary This test detects the presence of RNA from Marburg, Lassa, and Ebola viruses in clinical samples.
TEST-534 Maternal Lineage X-STR DNA Test This test identifies specific X-chromosome short tandem repeats (X-STRs) to determine maternal lineage.	Buccal swab or peripheral blood (EDTA tube)	10 calendar days	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["X-chromosome short tandem repeats (X-STRs)"] Parameters [{"name": "X-STR Maternal Lineage Test", "reference_range": null}] Preparation ["Inform phlebotomist about anticoagulant therapy if blood draw is chosen."] Indications ["Maternity disputes", "Immigration purposes", "Forensic casework", "Personal certainty of maternal lineage"] Measurement technique Confirm with laboratory Codes LOINC: 74322-5 ICD-10: Z13.89 Clinical summary This test identifies specific X-chromosome short tandem repeats (X-STRs) to determine maternal lineage.
TEST-2563 Maternal Myopathy with Cardiomyopathy (MMC) Mutation Detection Test This test detects pathogenic variants in genes associated with maternal myopathy with cardiomyopathy using NGS and PCR confirmation.	EDTA whole blood	10 business days	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in nuclear genes", "Pathogenic variants in mitochondrial genes"] Parameters [] Preparation ["No fasting required", "Complete Genomics Clinical Information Requisition Form (Form 20)"] Indications ["Diagnosis of suspected maternal myopathy with cardiomyopathy", "Carrier screening for individuals with family history", "Personalised cardiac surveillance planning"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: G71.0, I42.9 Clinical summary This test detects pathogenic variants in genes associated with maternal myopathy with cardiomyopathy using NGS and PCR confirmation.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Molecular Diagnostics tests in Dubai & UAE

Molecular Diagnostics test prices

Molecular Diagnostics: overview

Use the test details as a conversation starter

Related Molecular Diagnostics categories